Research has indicated that the symbiotic microbiota in mouse models of colon cancer is recognized by Toll-like receptors, which stimulate MyD88, resulting in upregulated expression of IL-23 and promotion of IL-17 secretion by Th17 cells, thus facilitating tumor progression. The gene discussed is IL17A; the disease is neoplasm.